PORCELLI, LETIZIA
 Distribuzione geografica
Continente #
NA - Nord America 1.779
AS - Asia 646
EU - Europa 500
SA - Sud America 200
AF - Africa 39
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.170
Nazione #
US - Stati Uniti d'America 1.746
SG - Singapore 277
BR - Brasile 180
CN - Cina 142
RU - Federazione Russa 116
SE - Svezia 110
HK - Hong Kong 90
IT - Italia 71
DE - Germania 56
VN - Vietnam 51
GB - Regno Unito 45
CA - Canada 23
CI - Costa d'Avorio 23
FI - Finlandia 23
FR - Francia 21
BE - Belgio 20
ID - Indonesia 14
IN - India 14
AT - Austria 10
JP - Giappone 9
TR - Turchia 9
IQ - Iraq 8
AR - Argentina 6
BD - Bangladesh 6
LT - Lituania 5
MX - Messico 5
PL - Polonia 5
TN - Tunisia 4
VE - Venezuela 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
CO - Colombia 3
EC - Ecuador 3
ES - Italia 3
KR - Corea 3
NL - Olanda 3
UZ - Uzbekistan 3
AL - Albania 2
BH - Bahrain 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
HN - Honduras 2
KE - Kenya 2
KW - Kuwait 2
KZ - Kazakistan 2
MA - Marocco 2
NP - Nepal 2
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CL - Cile 1
CW - ???statistics.table.value.countryCode.CW??? 1
DZ - Algeria 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
IE - Irlanda 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
MD - Moldavia 1
MT - Malta 1
NR - Nauru 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
UA - Ucraina 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.170
Città #
Ashburn 225
Fairfield 221
Woodbridge 167
Chandler 154
Singapore 148
Houston 94
Seattle 92
Hong Kong 90
Cambridge 87
Nyköping 83
Wilmington 67
Beijing 60
Ann Arbor 49
New York 41
Bari 37
Los Angeles 26
Lawrence 24
Abidjan 23
Munich 23
Roxbury 23
Brooklyn 22
Dallas 22
Ho Chi Minh City 21
Brussels 20
São Paulo 19
Moscow 14
The Dalles 13
Columbus 12
Nanjing 12
Des Moines 11
Hanoi 11
Jakarta 11
London 11
Paris 10
San Diego 10
Santa Clara 10
Dearborn 9
Tokyo 9
Turku 9
Helsinki 8
Montreal 7
Vienna 7
Boardman 6
Council Bluffs 6
Dong Ket 6
Inglewood 6
Miami 6
Monmouth Junction 6
Ankara 5
Brasília 5
Buffalo 5
Denver 5
Porto Alegre 5
San Francisco 5
Shanghai 5
Toronto 5
Warsaw 5
Baghdad 4
Belo Horizonte 4
Chennai 4
Detroit 4
Falkenstein 4
Falls Church 4
Frankfurt am Main 4
Nanchang 4
Napoli 4
Ottawa 4
Poplar 4
Pune 4
San Jose 4
Washington 4
Atlanta 3
Calgary 3
Changsha 3
Charlotte 3
Curitiba 3
Dhaka 3
Goiânia 3
Jiaxing 3
Joinville 3
Kunming 3
Leawood 3
Maringá 3
Marseille 3
Nuremberg 3
Orem 3
Phoenix 3
Princeton 3
Rio de Janeiro 3
Seoul 3
Shenyang 3
Stockholm 3
Tashkent 3
Almaty 2
Amsterdam 2
Barranquilla 2
Belford Roxo 2
Betim 2
Bitonto 2
Blumenau 2
Totale 2.229
Nome #
New insight into the role of metabolic reprogramming in melanoma cells harboring braf mutations. 200
Sorafenib delivery nanoplatform based on superparamagnetic iron oxide nanoparticles magnetically targets hepatocellular carcinoma 178
Drug delivery nanovectors based on SPIONS for targeted therapy of hepatocellular carcinoma 162
CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer 160
Gene Expression Comparison between the Lymph Node-Positive and -Negative Reveals a Peculiar Immune Microenvironment Signature and a Theranostic Role for WNT Targeting in Pancreatic Ductal Adenocarcinoma: A Pilot Study 157
Detrimental effects of melanocortin-1 receptor (MC1R) variants on the clinical outcomes of BRAF V600 metastatic melanoma patients treated with BRAF inhibitors 156
Small P-gp modulating molecules: SAR studies on tetrahydroisoquinoline derivatives 147
Targeting human liver cancer cells with lactobionic acid-G(4)-PAMAM-FITC sorafenib loaded dendrimers 140
Anti-EGFR monoclonal antibody in cancer treatment: In vitro and in vivo evidence 137
EGFR tyrosine kinases inhibitors in cancer treatment: in vitro and in vivo evidence 135
Potential predictive role of chemotherapy-induced changes of soluble CD40 ligand in untreated advanced pancreatic ductal adenocarcinoma 133
The coordinated role of CYP450 enzymes and P-gp in determining cancer resistance to chemotherapy 132
Optimize radiochemotherapy in pancreatic cancer: PARP inhibitors a new therapeutic opportunity 124
Synthetic lethality to overcome cancer drug resistance 118
p53 as the main traffic controller of the cell signaling network 114
Cyclohexylpiperazine derivative PB28, a σ2 agonist and σ1 antagonist receptor, inhibits cell growth, modulates P-glycoprotein, and synergizes with anthracyclines in breast cancer 96
Hydroxy-propil-β-cyclodextrin inclusion complexes of two biphenylnicotinamide derivatives: Formulation and anti-proliferative activity evaluation in pancreatic cancer cell models 92
null 86
Tomatine displays antitumor potential in in vitro models of metastatic melanoma 83
The β-adrenergic receptor antagonist propranolol offsets resistance mechanisms to chemotherapeutics in diverse sarcoma subtypes: a pilot study 80
Hepatic stellate cells induce hepatocellular carcinoma cell resistance to sorafenib through the laminin-332/α3 integrin axis recovery of focal adhesion kinase ubiquitination 78
Synergistic antiproliferative and antiangiogenic effects of EGFR and mTOR inhibitors 77
Long non‐coding rna landscape in prostate cancer molecular subtypes: A feature selection approach 73
null 71
BRAFV600E;K601Q metastatic melanoma patient-derived organoids and docking analysis to predict the response to targeted therapy 69
Gene Expression Comparison between Alcohol-Exposed Versus Not Exposed Pancreatic Ductal Adenocarcinoma Patients Reveals a Peculiar TGFβ-Related Phenotype: An Exploratory Analysis 67
The role of non-coding RNAs as prognostic factor, predictor of drug response or resistance and pharmacological targets, in the cutaneous squamous cell carcinoma 61
Probing the interaction between cisplatin and the therapeutic monoclonal antibody trastuzumab 60
Circulating extracellular vesicles are monitoring biomarkers of anti-PD1 response and enhancer of tumor progression and immunosuppression in metastatic melanoma 52
IRISIN AND METASTATIC MELANOMA: SELECTIVE ANTI-INVASIVENESS ACTIVITY IN BRAF WILD-TYPE CELLS 46
Cervical cancer benefits from trabectedin combination with the β-blocker propranolol: in vitro and ex vivo evaluations in patient-derived organoids 24
Totale 3.308
Categoria #
all - tutte 14.260
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.260


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021238 0 0 0 0 0 29 42 20 35 48 44 20
2021/2022262 9 31 3 3 21 30 10 15 20 22 29 69
2022/2023393 38 66 26 41 31 51 10 41 64 3 9 13
2023/2024149 16 19 14 11 23 42 2 8 4 3 0 7
2024/2025703 30 13 31 41 40 53 138 80 33 25 71 148
2025/2026742 218 69 96 140 181 38 0 0 0 0 0 0
Totale 3.308